Worldwide survey of neonatal screening for biotinidase deficiency

  • Bernhard Wolf
  • Published 1991 in Journal of Inherited Metabolic Disease

Abstract

Neonatal screening for biotinidase deficiency has been conducted in 14 countries since 1984. To 31 December 1990, 8 532 617 newborns were screened. One hundred and forty-two infants with biotinidase deficiency were identified; 76 infants with profound deficiency (<10% of mean normal serum activity) and 66 infants with partial deficiency (10–30% of mean normal activity). The estimated incidence of profound biotinidase deficiency is 1:112 271 (1:85 000 to 1:145 000; 95% confidence limits) and the incidence of partial deficiency is 1:129 282 (1:112 700 to 1:177 000). The incidence of combined profound and partial deficiency is 1:60 089 newborns (1:49 500 to 1:73 100). The estimated frequency of the allele for biotinidase deficiency is 0.004 and an estimated 1 in 123 individuals is heterozygous for the disorder.

DOI: 10.1007/BF01800475

1 Figure or Table

0200400'96'98'00'02'04'06'08'10'12'14'16
Citations per Year

2,240 Citations

Semantic Scholar estimates that this publication has 2,240 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Wolf1991WorldwideSO, title={Worldwide survey of neonatal screening for biotinidase deficiency}, author={Bernhard Wolf}, journal={Journal of Inherited Metabolic Disease}, year={1991}, volume={14}, pages={923-927} }